What are the characteristic cranial MRI findings in multiple sclerosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Characteristic Cranial MRI Findings in Multiple Sclerosis

Multiple sclerosis lesions on cranial MRI demonstrate asymmetric white matter involvement with characteristic anatomical distribution patterns, including periventricular lesions (particularly ovoid "Dawson's fingers" perpendicular to ventricles), juxtacortical/cortical lesions affecting U-fibers, infratentorial lesions, and corpus callosum involvement, with the central vein sign (CVS) present in most lesions serving as a highly specific diagnostic marker. 1

Key Anatomical Locations and Lesion Characteristics

Periventricular Lesions

  • Direct contact with lateral ventricles without intervening normal-appearing white matter 1
  • Ovoid lesions with long axis perpendicular to lateral ventricles, creating the classic "Dawson's fingers" appearance 1
  • Corpus callosum lesions that abut the ventricles are included in this category 1
  • Critical caveat: Lesions abutting ventricles but located in deep grey matter (e.g., thalamus) are NOT considered periventricular 1

Juxtacortical and Cortical Lesions

  • Hallmark feature rarely seen in other conditions 1
  • Affect U-fibers, which distinguishes MS from ischemia (U-fibers typically spared in vascular disease) 1
  • Cortical lesions without juxtacortical white matter involvement are difficult to detect on conventional MRI, even at 3T 1
  • Enhanced visualization with 3D sequences: DIR (double inversion recovery), PSIR (phase-sensitive inversion recovery), or MPRAGE 1

Infratentorial Lesions

Preferential involvement of specific structures 1:

  • Floor of the fourth ventricle
  • Surface of the pons
  • Intra-pontine trigeminal tracts
  • Middle and superior cerebellar peduncles
  • Periaqueductal grey matter
  • Cerebellar white matter and cortex
  • Medullary pyramids

Corpus Callosum

  • Lesions less than 3 mm at specific locations (floor of fourth ventricle, outer margin of pons, or corpus callosum) can still be considered demyelinating 1
  • Involvement is characteristic and diagnostically valuable 1

Lesion Size and Morphology Criteria

Generally, lesions should be at least 3 mm in longest diameter 1

Non-specific lesions to avoid misdiagnosis:

  • Lesions smaller than 3 mm, rounded, deep in white matter (especially basal frontal areas) without CVS are non-specific 1
  • Typically lesions are smaller than 1 cm in diameter, though larger lesions can occur 1

Deep White Matter Lesions

Low diagnostic specificity - not considered a characteristic anatomical location for demonstrating dissemination in space (DIS) 1

However, deep white matter lesions contribute to diagnosis when they:

  • Show gadolinium enhancement (indicating dissemination in time)
  • Harbor a central vein sign (CVS)
  • Display a paramagnetic rim 1

This is particularly important in patients older than 50 years or with vascular risk factors, where deep white matter lesions should ideally be ovoid, involve corpus callosum or temporal lobe, or show CVS/paramagnetic rim 1

Central Vein Sign (CVS) - Emerging Highly Specific Biomarker

Definition and Detection

  • Thin (<2 mm diameter) hypointense line or dot present in two perpendicular planes, running partially or entirely through lesion center 1
  • Detected with susceptibility-sensitive MRI sequences 1
  • Present in most MS lesions and found early in disease (including clinically isolated syndrome, radiologically isolated syndrome, and pediatric MS) 1

Diagnostic Criteria

Select 6 Rule (incorporated in 2024 McDonald criteria) 1:

  • Positive when 6 or more white matter lesions are CVS positive
  • If fewer than 10 white matter lesions detected, CVS-positive lesions should be the majority
  • Shows good sensitivity and excellent specificity for MS
  • 95% of radiologically isolated syndrome patients fulfill this rule

Optimal cutoff: At least 40-46% CVS-positive lesions best differentiates MS from common mimickers 1

Technical Considerations

  • Do NOT assess CVS in:
    • Lesions less than 3 mm in size
    • Confluent lesions containing multiple veins
    • Areas where veins are poorly visible 1
  • Higher field strengths (3.0T and 7.0T) improve CVS detection compared to 1.5T 1
  • Gadolinium administration before/during susceptibility-sensitive sequences improves CVS detection, especially recommended at 1.5T 1

Contrast Enhancement Patterns

  • Gadolinium enhancement indicates active inflammation and lesion age 1
  • Finding both enhancing and non-enhancing lesions on any single scan indicates dissemination in time (DIT) 1
  • Enhanced lesions greater than 1 cm diameter often become ring-shaped 2
  • Enhancement pattern depends on lesion age and timing after contrast injection 1

Temporal Evolution

New T2 lesions at any time during follow-up indicate DIT 1

Critical pitfall: Ensure new lesions are not artifacts from changes in MRI protocol or slice positioning 1

New T2 lesions do not necessarily need to be in the anatomical locations required for DIS criteria fulfillment 1

Common Diagnostic Pitfalls

The most common source of MS misdiagnosis is misinterpretation of MRI findings 1

Key Points to Avoid Misdiagnosis:

  1. MS lesions asymmetrically affect white matter of cerebral hemispheres 1
  2. Juxtacortical/cortical lesions with typical morphology are rarely encountered in other conditions 1
  3. CVS is rarely present in common MS mimickers (cerebral small vessel disease, AQP4+ NMOSD, migraine) 1
  4. Brainstem MS lesions follow predictable perivenular distribution patterns and rarely disappear on follow-up imaging 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.